The study is being done to compare the combination of lenalidomide and dexamethasone followed
by autologous peripheral blood stem cell transplant (PBSCT) and lenalidomide and
dexamethasone without PBSCT in patients with untreated multiple myeloma. This comparison will
include how the subjects respond to each study treatment combination, and what side effects
are caused by each combination.